1. answerboy79
2. wjohenning2756
3. spottedgecko7
4. zbzapp95
5. mevol77
1.wjohenning2756 02/21/2018
Announces publication of the results from the Phase 1
2.spottedgecko7 01/08/2018
Facts - TG Therapeutics and Jiangsu Hengrui Medicine Announce Global License Agreement for Development and Commercialization of Novel BTK Inhibitor Program for the Treatment of Hematologic Malignancie
3.answerboy79 02/21/2018
I bought in over a year ago
4.zbzapp95 02/21/2018
Seems like $20 getting closer every day
5.answerboy79 02/05/2018
More details
6.answerboy79 02/02/2018
Announces results from the Phase 2 multicenter trial of ublituximab (TG-1101) in relapsing forms of Multiple…
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW